HealthEquity, Inc. (HQY)
USD 82.36
(3.03%)
USD 82.36
(3.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 282.41 Million USD | 64.65% |
| 2023 | 171.52 Million USD | 16.47% |
| 2022 | 102.97 Million USD | -13.74% |
| 2021 | 154.92 Million USD | 28.18% |
| 2020 | 123.27 Million USD | 62.11% |
| 2019 | 94 Million USD | 36.22% |
| 2018 | 68.14 Million USD | 29.36% |
| 2017 | 54.39 Million USD | 56.57% |
| 2016 | 34.74 Million USD | 91.57% |
| 2015 | 22.76 Million USD | 15.77% |
| 2014 | 15.79 Million USD | 51.94% |
| 2013 | 10.19 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 60.5 Million USD | 9.98% |
| 2024 Q4 | 79.07 Million USD | 12.23% |
| 2024 Q1 | 67.5 Million USD | 16.91% |
| 2024 FY | - USD | 40.52% |
| 2024 Q2 | 67.88 Million USD | 2.8% |
| 2023 Q2 | 46.04 Million USD | 11.78% |
| 2023 FY | - USD | 16.47% |
| 2023 Q1 | 41.19 Million USD | 27.96% |
| 2023 Q3 | 52.99 Million USD | 15.1% |
| 2023 Q4 | 59.89 Million USD | 13.03% |
| 2022 Q2 | 50.55 Million USD | 22.71% |
| 2022 FY | - USD | -13.74% |
| 2022 Q1 | 41.19 Million USD | -15.54% |
| 2022 Q4 | 32.19 Million USD | -9.69% |
| 2022 Q3 | 35.64 Million USD | -29.5% |
| 2021 Q3 | 48.65 Million USD | 3.15% |
| 2021 Q2 | 47.16 Million USD | -13.59% |
| 2021 Q1 | 54.58 Million USD | 4.92% |
| 2021 Q4 | 48.77 Million USD | 0.25% |
| 2021 FY | - USD | 28.18% |
| 2020 Q2 | 35.38 Million USD | 9.03% |
| 2020 Q3 | 15.71 Million USD | -55.58% |
| 2020 Q4 | 52.02 Million USD | 231.0% |
| 2020 FY | - USD | 62.11% |
| 2020 Q1 | 32.45 Million USD | 52.58% |
| 2019 Q3 | 23.56 Million USD | -9.21% |
| 2019 Q4 | 21.26 Million USD | -9.76% |
| 2019 FY | - USD | 36.22% |
| 2019 Q1 | 25.06 Million USD | 89.22% |
| 2019 Q2 | 25.95 Million USD | 3.59% |
| 2018 Q4 | 13.24 Million USD | -24.61% |
| 2018 Q2 | 20.14 Million USD | 3.81% |
| 2018 Q1 | 19.4 Million USD | 97.57% |
| 2018 FY | - USD | 29.36% |
| 2018 Q3 | 17.56 Million USD | -12.81% |
| 2017 Q3 | 12.46 Million USD | -21.72% |
| 2017 Q2 | 15.91 Million USD | -1.73% |
| 2017 Q1 | 16.19 Million USD | 203.31% |
| 2017 FY | - USD | 56.57% |
| 2017 Q4 | 9.82 Million USD | -21.16% |
| 2016 Q1 | 8.39 Million USD | 259.82% |
| 2016 FY | - USD | 91.57% |
| 2016 Q4 | 5.34 Million USD | -20.45% |
| 2016 Q3 | 6.71 Million USD | -15.1% |
| 2016 Q2 | 7.9 Million USD | -5.77% |
| 2015 Q3 | 4.7 Million USD | -13.56% |
| 2015 Q4 | 2.33 Million USD | -50.41% |
| 2015 FY | - USD | 15.77% |
| 2015 Q1 | 6.64 Million USD | 167.92% |
| 2015 Q2 | 5.44 Million USD | -18.14% |
| 2014 Q4 | 2.48 Million USD | -46.71% |
| 2014 FY | - USD | 51.94% |
| 2014 Q3 | 4.65 Million USD | 1.39% |
| 2014 Q1 | 3.83 Million USD | 0.0% |
| 2014 Q2 | 4.59 Million USD | 19.8% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ontrak, Inc. | -14.41 Million USD | 2059.046% |
| iCoreConnect Inc. | -11.87 Million USD | 2477.361% |
| Augmedix, Inc. | -17.68 Million USD | 1697.285% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 19.198% |
| CareCloud, Inc. | -31.29 Million USD | 1002.576% |
| CareCloud, Inc. | -31.29 Million USD | 1002.576% |
| Inovalon Holdings, Inc. | 186.56 Million USD | -51.378% |
| Nutex Health, Inc. | -14.58 Million USD | 2036.829% |
| OneMedNet Corporation | -11.97 Million USD | 2459.216% |
| Progyny, Inc. | 64.46 Million USD | -338.092% |
| Omnicell, Inc. | 60.69 Million USD | -365.342% |
| Renalytix Plc | -28.52 Million USD | 1090.204% |
| Schrödinger, Inc. | -171.89 Million USD | 264.295% |
| Simulations Plus, Inc. | 6.13 Million USD | -4506.361% |
| SOPHiA GENETICS SA | -70.7 Million USD | 499.457% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 2303.62% |
| Minerva Surgical, Inc. | -20.07 Million USD | 1506.945% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 92.067% |
| Sharecare, Inc. | -67.25 Million USD | 519.924% |
| Aclarion, Inc. | -4.14 Million USD | 6920.962% |
| CareMax, Inc. | -590.46 Million USD | 147.83% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 5453.802% |
| Forian Inc. | 2.75 Million USD | -10168.586% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 5453.802% |
| HeartBeam, Inc. | 675 Thousand USD | -41739.407% |
| GeneDx Holdings Corp. | -136.46 Million USD | 306.959% |
| SCWorx Corp. | -3.97 Million USD | 7205.35% |
| Definitive Healthcare Corp. | -241.22 Million USD | 217.075% |
| 10x Genomics, Inc. | -205.11 Million USD | 237.689% |
| Zhongchao Inc. | -4.9 Million USD | 5860.825% |
| Accolade, Inc. | -71.19 Million USD | 496.691% |
| MSP Recovery, Inc. | -69.22 Million USD | 507.992% |
| R1 RCM Inc. | 426.2 Million USD | 33.736% |
| Spok Holdings, Inc. | 26.29 Million USD | -973.948% |
| Privia Health Group, Inc. | 27.18 Million USD | -938.982% |
| EUDA Health Holdings Limited | -8.3 Million USD | 3502.455% |
| TruBridge, Inc. | -15.39 Million USD | 1934.942% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 19.198% |
| Sharecare, Inc. | -67.25 Million USD | 519.924% |
| Health Catalyst, Inc. | -66.46 Million USD | 524.929% |
| GoodRx Holdings, Inc. | 108.82 Million USD | -159.516% |
| Premier, Inc. | 286.08 Million USD | 1.284% |
| HealthStream, Inc. | 59.58 Million USD | -373.956% |
| Certara, Inc. | 23.84 Million USD | -1084.432% |
| GeneDx Holdings Corp. | -136.46 Million USD | 306.959% |
| Ontrak, Inc. | -14.41 Million USD | 2059.046% |
| SHL Telemedicine Ltd. | 3.28 Million USD | -8501.029% |
| CareCloud, Inc. | -31.29 Million USD | 1002.576% |
| EUDA Health Holdings Limited | -8.3 Million USD | 3502.455% |
| HeartBeam, Inc. | 675 Thousand USD | -41739.407% |
| Mangoceuticals, Inc. | -9.18 Million USD | 3173.906% |
| CareMax, Inc. | -590.46 Million USD | 147.83% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 6981.481% |
| National Research Corporation | 45.98 Million USD | -514.148% |
| Aclarion, Inc. | -4.14 Million USD | 6920.962% |
| OptimizeRx Corporation | -21.3 Million USD | 1425.374% |